Menu
Back to Journals » Cancer Management and Research » Volume 9 » default
Cancer Management and Research
ISSN: 1179-1322
- View all (4485)
- Volume 15, 2023 (44)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Archive: Volume 9, 2017
Clinical significance of miR-34a expression in thyroid diseases – an 18F-FDG PET-CT study
Chen L, Yang C, Feng J, Liu X, Tian Y, Zhao L, Xie R, Liu C, Zhao S, Sun H
Cancer Management and Research 2017, 9:903-913
Published Date: 15 December 2017
Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics
Peng J, Zhang L, Yuan CW, Zhou LH, Xu SG, Lin YP, Zhang J, Yin WJ, Lu JS
Cancer Management and Research 2017, 9:891-901
Published Date: 14 December 2017
ZNF259 inhibits non-small cell lung cancer cells proliferation and invasion by FAK-AKT signaling
Shan Y, Cao W, Wang T, Jiang G, Zhang Y, Yang X
Cancer Management and Research 2017, 9:879-889
Published Date: 14 December 2017
Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach
Batista TP, Carneiro VCG, Tancredi R, Teles ALB, Badiglian-Filho L, Leão CS
Cancer Management and Research 2017, 9:869-878
Published Date: 13 December 2017
Systemic immune–inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy
Chen L, Yan Y, Zhu L, Cong X, Li S, Song S, Song H, Xue Y
Cancer Management and Research 2017, 9:849-867
Published Date: 14 December 2017
Observation of different tumor motion magnitude within liver and estimate of internal motion margins in postoperative patients with hepatocellular carcinoma
Zhao YT, Liu ZK, Wu QW, Dai JR, Zhang T, Jia AY, Jin J, Wang SL, Li YX, Wang WH
Cancer Management and Research 2017, 9:839-848
Published Date: 12 December 2017
Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas
Xu P, Zhao Y, Liu K, Lin S, Liu X, Wang M, Yang P, Tian T, Zhu Y, Dai Z
Cancer Management and Research 2017, 9:821-837
Published Date: 12 December 2017
Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer
Wu SG, Zhang WW, He ZY, Sun JY, Wang Y, Zhou J
Cancer Management and Research 2017, 9:813-819
Published Date: 11 December 2017
The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor
Chen Y, Guo W, Fan J, Chen Y, Zhang X, Chen X, Luo P
Cancer Management and Research 2017, 9:801-811
Published Date: 7 December 2017
Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study
Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E
Cancer Management and Research 2017, 9:789-800
Published Date: 7 December 2017
Sites of metastasis and overall survival in esophageal cancer: a population-based study
Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L
Cancer Management and Research 2017, 9:781-788
Published Date: 6 December 2017
Low expression of GATA3 promotes cell proliferation and metastasis in gastric cancer
Wei S, Zhong L, Wang X, Zhang W
Cancer Management and Research 2017, 9:769-780
Published Date: 7 December 2017
Can 18F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumors
Nakagawa K, Takahashi S, Endo M, Ohde Y, Kurihara H, Terauchi T
Cancer Management and Research 2017, 9:761-768
Published Date: 5 December 2017
Bidirectional risk between venous thromboembolism and cancer in East Asian patients: synthesis of evidence from recent population-based epidemiological studies
Kok VC
Cancer Management and Research 2017, 9:751-759
Published Date: 5 December 2017
Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma
Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M
Cancer Management and Research 2017, 9:741-750
Published Date: 30 November 2017
The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma
Shafrin J, Sullivan J, Chou JW, Neely MN, Doan JF, Maclean JR
Cancer Management and Research 2017, 9:731-739
Published Date: 29 November 2017
The burden of selected cancers in the US: health behaviors and health care resource utilization
Iadeluca L, Mardekian J, Chander P, Hopps M, Makinson GT
Cancer Management and Research 2017, 9:721-730
Published Date: 28 November 2017
Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients
Chang CM, Hsieh MS, Yang TC, Hsieh VC, Chiang JH, Huang HH, How CK, Hu SY, Yen DH
Cancer Management and Research 2017, 9:709-720
Published Date: 28 November 2017
Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer
Xiao BY, Peng JH, Zhang RX, Xu J, Wang YC, Fang YJ, Lin JZ, Pan ZZ, Wu XJ
Cancer Management and Research 2017, 9:701-708
Published Date: 27 November 2017
Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients
Zhang SR, Wu TC, Peng XG, Liu J, Liu F, Wu SY, Liu SY, Dong Y, Xie SJ, Ma SL
Cancer Management and Research 2017, 9:691-700
Published Date: 23 November 2017
Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals
Wang Z, Xie H, Guo LP, Cai QL, Shang ZQ, Jiang N, Niu YJ
Cancer Management and Research 2017, 9:679-689
Published Date: 21 November 2017
Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma
Lin Z, Lv WZ, Wang SY, Zou JL, Con YY, Wang ZH, Xiao M, Peng PJ
Cancer Management and Research 2017, 9:671-677
Published Date: 20 November 2017
Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials
Li S, Zhou K, Che G, Yang M, Su J, Shen C, Yu P
Cancer Management and Research 2017, 9:657-670
Published Date: 16 November 2017
Association between unilateral or bilateral mastectomy and breast cancer death in patients with unilateral ductal carcinoma
Agarwal S, Pappas L, Agarwal J
Cancer Management and Research 2017, 9:649-656
Published Date: 16 November 2017
Expression of minichromosome maintenance genes in renal cell carcinoma
Zhong HB, Chen B, Neves H, Xing JC, Ye YX, Lin Y, Zhuang GH, Zhang SD, Huang JY, Kwok HF
Cancer Management and Research 2017, 9:637-647
Published Date: 15 November 2017
Risk factors for hypocalcemia and hypoparathyroidism following thyroidectomy: a retrospective Chinese population study
Wang Y, Bhandari A, Yang F, Zhang W, Xue L, Liu H, Zhang X, Chen C
Cancer Management and Research 2017, 9:627-635
Published Date: 15 November 2017
Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study
Dong F, Shen Y, Gao F, Xu T, Wang X, Zhang X, Zhong S, Zhang M, Chen S, Shen Z
Cancer Management and Research 2017, 9:611-626
Published Date: 14 November 2017
Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200
Gorczynski RM, Zhu F
Cancer Management and Research 2017, 9:601-609
Published Date: 13 November 2017
Training surgeons in shared decision-making with cancer patients aged 65 years and older: a pilot study
Geessink NH, Schoon Y, Olde Rikkert MGM, van Goor H
Cancer Management and Research 2017, 9:591-600
Published Date: 10 November 2017
Exome and transcriptome sequencing identifies loss of PDLIM2 in metastatic colorectal cancers
Oh BY, Cho J, Hong HK, Bae JS, Park WY, Joung JG, Cho YB
Cancer Management and Research 2017, 9:581-589
Published Date: 8 November 2017
Characteristics and prognostic factors of colorectal mucinous adenocarcinoma with signet ring cells
Kong XQ, Zhang XQ, Huang YX, Tang LR, Peng QQ, Li JL
Cancer Management and Research 2017, 9:573-580
Published Date: 2 November 2017
Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells
Zheng HL, Hong H, Zhang LL, Cai X, Hu M, Cai YP, Zhou B, Lin JY, Zhao CG, Hu WL
Cancer Management and Research 2017, 9:565-572
Published Date: 1 November 2017
Potential role of radiation therapy in augmenting the activity of immunotherapy for gynecologic cancers
Son CH, Fleming GF, Moroney JW
Cancer Management and Research 2017, 9:553-563
Published Date: 31 October 2017
Clinical aspects of foot health and their influence on quality of life among breast cancer survivors: a case–control study
Palomo-López P, Rodríguez-Sanz D, Becerro-de-Bengoa-Vallejo R, Losa-Iglesias ME, Guerrero-Martín J, Calvo-Lobo C, López-López D
Cancer Management and Research 2017, 9:545-551
Published Date: 1 November 2017
High expression of eIF3d is associated with poor prognosis in patients with gastric cancer
He JQ, Wang XF, Cai JH, Wang W, Qin XY
Cancer Management and Research 2017, 9:539-544
Published Date: 25 October 2017
Partial hepatectomy for spontaneous tumor rupture in patients with hepatocellular carcinoma: a retrospective cohort study
Zhu Q, Qiao G, Xu C, Guo D, Tang J, Duan R, Li Y
Cancer Management and Research 2017, 9:525-537
Published Date: 19 October 2017
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center
Yu HH, Yonemura Y, Hsieh MC, Mizumoto A, Wakama S, Lu CY
Cancer Management and Research 2017, 9:513-523
Published Date: 19 October 2017
Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging
Yokoo T, Patel AD, Lev-Cohain N, Singal AG, Yopp AC, Pedrosa I
Cancer Management and Research 2017, 9:503-511
Published Date: 16 October 2017
A structured group exercise program for patients with metastatic cancer receiving chemotherapy and CTNNB1 (β-catenin) as a biomarker of exercise efficacy
Chiarotto JA, Akbarali R, Bellotti L, Dranitsaris G
Cancer Management and Research 2017, 9:495-501
Published Date: 13 October 2017
Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κB pathway in human colon cancer cell
Ma J, Sun X, Guo T, Su H, Chen Q, Gong Z, Qi J, Zhao X
Cancer Management and Research 2017, 9:481-493
Published Date: 9 October 2017
Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: a population-based study
Tao LY, Yuan CH, Ma ZL, Jiang B, Xiu DR
Cancer Management and Research 2017, 9:471-479
Published Date: 3 October 2017
Emerging combination therapies for metastatic colorectal cancer – impact of trifluridine/tipiracil
Puthiamadathil JM, Weinberg BA
Cancer Management and Research 2017, 9:461-469
Published Date: 3 October 2017
Postoperative radiotherapy for invasive micropapillary carcinoma of the breast: an analysis of Surveillance, Epidemiology, and End Results database
Wu SG, Zhang WW, Sun JY, Li FY, Chen YX, He ZY
Cancer Management and Research 2017, 9:453-459
Published Date: 3 October 2017
Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma
Li YJ, Yang X, Zhang WB, Yi C, Wang F, Li P
Cancer Management and Research 2017, 9:443-451
Published Date: 28 September 2017
Challenging the standard of care in advanced melanoma: focus on pembrolizumab
Abdul-Karim RM, Cowey CL
Cancer Management and Research 2017, 9:433-442
Published Date: 25 September 2017
Unintended target effect of anti-BCL-2 DNAi
Ebrahim AS, Kandouz M, Emara N, Sugalski AB, Lipovich L, Al-Katib AM
Cancer Management and Research 2017, 9:427-432
Published Date: 22 September 2017
Is the prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis
Meng W, Jiang Y, Ma J
Cancer Management and Research 2017, 9:411-425
Published Date: 20 September 2017
A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia
Bainer RO, Trendowski MR, Cheng C, Pei D, Yang W, Paugh SW, Goss KH, Skol AD, Pavlidis P, Pui CH, Gilliam TC, Evans WE, Onel K
Cancer Management and Research 2017, 9:397-410
Published Date: 13 September 2017
Standard of care and direct medical costs of the treatment of chronic lymphocytic leukemia among the adult population in Ukraine, Russia, and Kazakhstan: data from the LEUKOSPECT study
Vasylyev A, Molostvova V, Rebrov BA, Makarova J, Zaritskey A, Ptushkin V, Ramazanova R, Popovych Y, Tsyapka O, Pashanov E
Cancer Management and Research 2017, 9:387-395
Published Date: 7 September 2017
SIRT1 gene polymorphisms and risk of lung cancer
Lv Y, Lin SY, Peng F
Cancer Management and Research 2017, 9:381-386
Published Date: 4 September 2017
Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study
Chen R, Zhang X, Gao C, Luan C, Wang Y, Chen B
Cancer Management and Research 2017, 9:373-380
Published Date: 24 August 2017
Head and neck cancer: improving outcomes with a multidisciplinary approach
Lo Nigro C, Denaro N, Merlotti A, Merlano M
Cancer Management and Research 2017, 9:363-371
Published Date: 18 August 2017
Vaginal cuff brachytherapy in endometrial cancer – a technically easy treatment?
Sabater S, Andres I, Lopez-Honrubia V, Berenguer R, Sevillano M, Jimenez-Jimenez E, Rovirosa A, Arenas M
Cancer Management and Research 2017, 9:351-362
Published Date: 9 August 2017
Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives
Serrano NA, Kalman NS, Anscher MS
Cancer Management and Research 2017, 9:339-350
Published Date: 28 July 2017
Survivorship of patients with head and neck cancer receiving care in a tertiary health facility in Nigeria
Okwor VC, Fagbamigbe AF, Fawole OI
Cancer Management and Research 2017, 9:331-338
Published Date: 21 July 2017
Exploring the acceptability of human papillomavirus self-sampling among Muslim immigrant women
Lofters AK, Vahabi M, Fardad M, Raza A
Cancer Management and Research 2017, 9:323-329
Published Date: 19 July 2017
The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix
Zhou J, Zhang WW, Wu SG, He ZY, Sun JY, Wang Y, Chen QH
Cancer Management and Research 2017, 9:315-322
Published Date: 18 July 2017
Emerging combination therapies for the management of multiple myeloma: the role of elotuzumab
Chen WC, Kanate AS, Craig M, Petros WP, Hazlehurst LA
Cancer Management and Research 2017, 9:307-314
Published Date: 12 July 2017
Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives
El-Amm J, Nassabein R, Aragon-Ching JB
Cancer Management and Research 2017, 9:299-306
Published Date: 11 July 2017
Induction regimens for transplant-eligible patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials
Zeng ZH, Chen JF, Li YX, Zhang R, Xiao L, Meng XY
Cancer Management and Research 2017, 9:287-298
Published Date: 10 July 2017
Estrogen-mediated hemangioma-derived stem cells through estrogen receptor-α for infantile hemangioma
Zhang L, Wu H, Yuan W, Zheng J
Cancer Management and Research 2017, 9:279-286
Published Date: 7 July 2017
What we know about surgical therapy in early-stage non-small-cell lung cancer: a guide for the medical oncologist
Ghanem S, El Bitar S, Hossri S, Weerasinghe C, Atallah JP
Cancer Management and Research 2017, 9:267-278
Published Date: 6 July 2017
Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
Simkens GA, Rovers KP, Nienhuijs SW, de Hingh IH
Cancer Management and Research 2017, 9:259-266
Published Date: 30 June 2017
Tumor cell PD-L1 predicts poor local control for rectal cancer patients following neoadjuvant radiotherapy
Shao LD, Peng QQ, Du KX, He JY, Dong YP, Lin XY, Li JL, Wu JX
Cancer Management and Research 2017, 9:249-258
Published Date: 29 June 2017
Comparison of gefitinib as first- and second-line therapy for advanced lung adenocarcinoma patients with positive exon 21 or 19 del epidermal growth factor receptor mutation
Patel N, Wu P, Zhang H
Cancer Management and Research 2017, 9:243-248
Published Date: 28 June 2017
Management of malignant pleural effusion: challenges and solutions
Penz E, Watt KN, Hergott CA, Rahman NM, Psallidas I
Cancer Management and Research 2017, 9:229-241
Published Date: 23 June 2017
Chemotherapy-associated paronychia treated with 2% povidone–iodine: a series of cases
Capriotti K, Capriotti J, Pelletier J, Stewart K
Cancer Management and Research 2017, 9:225-228
Published Date: 26 June 2017
Emerging use of everolimus in the treatment of neuroendocrine tumors
Gajate P, Martínez-Sáez O, Alonso-Gordoa T, Grande E
Cancer Management and Research 2017, 9:215-224
Published Date: 20 June 2017
Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
Chuzi S, Tavora F, Cruz M, Costa R, Chae YK, Carneiro BA, Giles FJ
Cancer Management and Research 2017, 9:207-213
Published Date: 14 June 2017
Can biosimilars help achieve the goals of US health care reform?
Boccia R, Jacobs I, Popovian R, de Lima Lopes Jr G
Cancer Management and Research 2017, 9:197-205
Published Date: 1 June 2017
Multiple myeloma in Niger Delta, Nigeria: complications and the outcome of palliative interventions
Nwabuko OC, Igbigbi EE, Chukwuonye II, Nnoli MA
Cancer Management and Research 2017, 9:189-196
Published Date: 22 May 2017
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide–based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial
Schnadig ID, Agajanian R, Dakhil C, Gabrail N, Vacirca J, Taylor C, Wilks S, Braun E, Mosier MC, Geller RB, Schwartzberg L, Vogelzang N
Cancer Management and Research 2017, 9:179-187
Published Date: 19 May 2017
Considering renal risk while managing cancer
Shahinian VB, Bahl A, Niepel D, Lorusso V
Cancer Management and Research 2017, 9:167-178
Published Date: 16 May 2017
Oligodendrogliomas in pediatric and adult patients: an outcome-based study from the Surveillance, Epidemiology, and End Result database
Lau CSM, Mahendraraj K, Chamberlain RS
Cancer Management and Research 2017, 9:159-166
Published Date: 2 May 2017
Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment
González JM, Ogale S, Morlock R, Posner J, Hauber B, Sommer N, Grothey A
Cancer Management and Research 2017, 9:149-158
Published Date: 27 April 2017
Comparative effectiveness and resource utilization of nab-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcinoma in a US community setting
Braiteh F, Patel MB, Parisi M, Ni Q, Park S, Faria C
Cancer Management and Research 2017, 9:141-148
Published Date: 21 April 2017
Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape
Subramanian J, Cavenagh J, Desai B, Jacobs I
Cancer Management and Research 2017, 9:131-140
Published Date: 24 April 2017
Drainage of malignant ascites: patient selection and perspectives
Stukan M
Cancer Management and Research 2017, 9:115-130
Published Date: 12 April 2017
The clinical development of obinutuzumab for the treatment of follicular lymphoma
Ma B, Ujjani C
Cancer Management and Research 2017, 9:103-113
Published Date: 10 April 2017
Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia
Alakel N, Stölzel F, Mohr B, Kramer M, Oelschlägel U, Röllig C, Bornhäuser M, Ehninger G, Schaich M
Cancer Management and Research 2017, 9:97-102
Published Date: 29 March 2017
nab-Paclitaxel for the treatment of pancreatic cancer
Kim G
Cancer Management and Research 2017, 9:85-96
Published Date: 16 March 2017
New developments in the management of Waldenström macroglobulinemia
Abeykoon JP, Yanamandra U, Kapoor P
Cancer Management and Research 2017, 9:73-83
Published Date: 10 March 2017
Glucocorticoid receptor expression in 20 solid tumor types using immunohistochemistry assay
Block TS, Murphy TI, Munster PN, Nguyen DP, Lynch FJ
Cancer Management and Research 2017, 9:65-72
Published Date: 6 March 2017
Update on the optimal use of bortezomib in the treatment of multiple myeloma
Mohan M, Matin A, Davies FE
Cancer Management and Research 2017, 9:51-63
Published Date: 2 March 2017
Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting
Rapoport BL
Cancer Management and Research 2017, 9:41-50
Published Date: 22 February 2017
Feasibility of an exercise intervention for fatigued breast cancer patients at a community-based cardiac rehabilitation program
De Jesus S, Fitzgeorge L, Unsworth K, Massel D, Suskin N, Prapavessis H, Sanatani M
Cancer Management and Research 2017, 9:29-39
Published Date: 10 February 2017
Prospect of the use of checkpoint inhibitors in hepatocellular cancer treatments
Raufi A, Tirona MT
Cancer Management and Research 2017, 9:19-27
Published Date: 9 February 2017
Antioxidant activity of ginger extract as a daily supplement in cancer patients receiving adjuvant chemotherapy: a pilot study
Danwilai K, Konmun J, Sripanidkulchai B, Subongkot S
Cancer Management and Research 2017, 9:11-18
Published Date: 31 January 2017
Association of fatigue and depression with circulating levels of proinflammatory cytokines and epidermal growth factor receptor ligands: a correlative study of a placebo-controlled fatigue trial
Rich T, Zhao F, Cruciani RA, Cella D, Manola J, Fisch MJ
Cancer Management and Research 2017, 9:1-10
Published Date: 31 January 2017